Atas, N. Et Al. 2021. Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5 .

Atas, N., Eroglu, G. A., Sodan, H. N., Ozturk, B. O., Babaoglu, H., Satis, H., ... Karadeniz, H.(2021). Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5.

Atas, N. Et Al. "Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5, 2021

Atas, N. Et Al. "Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5, 2021

Atas, N. Et Al. (2021) . "Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5.

@article{article, author={N. Atas Et Al. }, title={Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2021}